| Title |
“I knew what was going to happen if I did nothing and so I was going to do something”: Faith, hope, and trust in the decisions of Canadians with multiple sclerosis to seek unproven interventions abroad
|
|---|---|
| Published in |
BMC Health Services Research, September 2014
|
| DOI | 10.1186/1472-6963-14-445 |
| Pubmed ID | |
| Authors |
Jeremy Snyder, Krystyna Adams, Valorie A Crooks, David Whitehurst, Jennifer Vallee |
| Abstract |
Chronic cerebrospinal venous insufficiency (CCSVI) treatment is an unproven intervention aimed at relieving some of the symptoms of multiple sclerosis (MS). Despite limited evidence of the efficacy and safety of this intervention, Canadians diagnosed with MS have been traveling abroad to access this procedure as it is not available domestically outside of limited clinical trials. This paper discusses the experiences of Canadians with MS seeking CCSVI treatment abroad. |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 5 | 36% |
| United Kingdom | 1 | 7% |
| Unknown | 8 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 50% |
| Scientists | 3 | 21% |
| Practitioners (doctors, other healthcare professionals) | 3 | 21% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 2% |
| Canada | 1 | 2% |
| Unknown | 61 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 22% |
| Unspecified | 9 | 14% |
| Student > Doctoral Student | 6 | 10% |
| Student > Ph. D. Student | 6 | 10% |
| Researcher | 5 | 8% |
| Other | 10 | 16% |
| Unknown | 13 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 16% |
| Unspecified | 9 | 14% |
| Psychology | 9 | 14% |
| Social Sciences | 6 | 10% |
| Business, Management and Accounting | 4 | 6% |
| Other | 7 | 11% |
| Unknown | 18 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2017.
All research outputs
#844,343
of 25,119,447 outputs
Outputs from BMC Health Services Research
#198
of 8,525 outputs
Outputs of similar age
#8,893
of 259,293 outputs
Outputs of similar age from BMC Health Services Research
#6
of 153 outputs
Altmetric has tracked 25,119,447 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,525 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,293 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 153 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.